Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 2.73%. However, over the past six months, we’ve seen a weaker performance of 107.22%. The price of CDXC leaped by -18.90% over the last 30 days. And in the last five days, it has surged by 2.73%.
In terms of market performance, Chromadex Corp had a fairly even. The highest value for the stock in the past year was $7.97 on 11/29/24, and the lowest value was recorded at $1.36 on 01/23/24.
52-week price history of CDXC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Chromadex Corp’s current trading price is -31.65% away from its 52-week high, while its distance from the 52-week low is 300.74%. The stock’s price range during this period has varied between$1.36 and $7.97. The Chromadex Corp’s shares, which operate in the Consumer Defensive, saw a trading volume of around 0.24 million for the day, a figure considerably lower than their average daily volume of 1.3 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Chromadex Corp (CDXC) has experienced a quarterly rise of 66.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 416.29M and boasts a workforce of 106 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.85, with a change in price of +2.15. Similarly, Chromadex Corp recorded 919,578 in trading volume during the last 100 days, posting a change of +65.40%.
CDXC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CDXC stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.05.
CDXC Stock Stochastic Average
Chromadex Corp’s raw stochastic average for the past 50 days is presently 43.71%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 17.47%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.25% and 12.01%, respectively.
